Roche shelved these psychiatry drugs. So its former head of neuro cooked up some new plans — and raised $59M for his startup
As the former head of neuroscience product development at Roche for a decade, George Garibaldi can personally vouch for the quality of what the Swiss …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.